רופילק 300

Země: Izrael

Jazyk: hebrejština

Zdroj: Ministry of Health

Aktivní složka:

ANTI-D IMMUNOGLOBULINS

Dostupné s:

CSL BEHRING LTD., ISRAEL

ATC kód:

J06BB01

Léková forma:

תמיסה להזרקה

Složení:

ANTI-D IMMUNOGLOBULINS 150 MCG/ML

Podání:

תוך-שרירי, תוך-ורידי

Druh předpisu:

מרשם נדרש

Výrobce:

CSL BEHRING AG, SWITZERLAND

Terapeutické skupiny:

ANTI-D (RH) IMMUNOGLOBULIN

Terapeutické oblasti:

ANTI-D (RH) IMMUNOGLOBULIN

Terapeutické indikace:

Prophylaxis of Rh (D) immunisation in Rh (D)-negative women: Anti-D immune globulin is administered for the prevention of Rh (D) immunization if it has been demonstrated or if it is suspected that fetal erythrocytes have entered the circulation of the mother. Treatment is not necessary when it is assured that the child or the father are Rh (D)- negative. Criteria for a rhesus-incompatible pregnancy and the administration of anti-D immune globulin are : a) the mother is Rh (D) -negative b) the child is either Rh (D)-positive Rh (D)weak - positive or its rhesus type is not known. Routine antepartum prophylaxis : To prevent Rh (D) immunisation due to spontaneous fetomaternal haemorrhage (FMH) during the last trimester of pregnancy. Postpartum prophylaxis To prevent Rh (D) immunisation of the Rh (D)-negative mother following delivery of a Rh (D)-positive child. Complications of pregnancy: Interventions during pregnancy such as invasive prenatal diagnosis (e.g. amniocentesis chorionic villus sampling fetal blood s

Datum autorizace:

2023-02-28